Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 343Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Acceleration of rare disease therapeutic development: a case study of AGIL-AADC
Sonya Das,Samuel Huang,Andrew W. Lo
Drug Discovery Today.2019;24(3)678
2Regulations and Guidelines for Planning and Design of Multi-regional Clinical Trials
Yun-Kyoung Song,Minji Sohn,Ah Young Jeon,Jae Hyun Kim,Eunhee Ji,Jung Mi Oh,In-Wha Kim
Korean Journal of Clinical Pharmacy.2018;28(2)146
3Strategic inclusion of regions in multiregional clinical trials
Seung Yeon Song,Deborah Chee,EunYoung Kim
Clinical Trials.2019;16(1)98
4Cell-Based Therapies for Stroke: Are We There Yet?
Mirja Krause,Thanh G. Phan,Henry Ma,Christopher G. Sobey,Rebecca Lim
Frontiers in Neurology.2019;10(1)98
5Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan
Mitsuhiro Rokuda,Naoki Matsumaru,Katsura Tsukamoto
Clinical Therapeutics.2018;40(2)284
6Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 20152016
Yao Qiao,G Caleb Alexander,Thomas J Moore
Clinical Trials.2019;16(3)329
7Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 20152016
Basant Amarji,Sara Nidal Abed,Ujjawal Bairagi,Pran Kishore Deb,Omar Al-Attraqchi,Anup Avijit Choudhury,Rakesh K. Tekade
Clinical Trials.2018;16(3)637
8Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited
Dario Tedesco,Mufiza Farid-Kapadia,Martin Offringa,Zulfiqar A. Bhutta,Yvonne Maldonado,John P.A. Ioannidis,Despina G. Contopoulos-Ioannidis
Journal of Clinical Epidemiology.2018;95(3)63

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal